ACTI.ST
Price:
$0.162
Market Cap:
$173.85M
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Bio...[Read more]
Industry
Biotechnology
IPO Date
2003-12-19
Stock Exchange
STO
Ticker
ACTI.ST
According to Active Biotech AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 167.65M. This represents a change of 218.02% compared to the average of 52.72M of the last 4 quarters.
The mean historical Enterprise Value of Active Biotech AB (publ) over the last ten years is 147.87M. The current 167.65M Enterprise Value has changed 11.24% with respect to the historical average. Over the past ten years (40 quarters), ACTI.ST's Enterprise Value was at its highest in in the September 2017 quarter at 417.46M. The Enterprise Value was at its lowest in in the December 2014 quarter at -34469654.95.
Average
147.87M
Median
95.43M
Minimum
-30144053.92
Maximum
356.22M
Discovering the peaks and valleys of Active Biotech AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 41.27%
Maximum Annual Enterprise Value = 356.22M
Minimum Annual Increase = -1047.43%
Minimum Annual Enterprise Value = -30144053.92
Year | Enterprise Value | Change |
---|---|---|
2023 | 22.33M | -66.02% |
2022 | 65.73M | -4.44% |
2021 | 68.79M | -31.02% |
2020 | 99.73M | 9.45% |
2019 | 91.12M | -74.42% |
2018 | 356.22M | 41.27% |
2017 | 252.15M | -5.61% |
2016 | 267.14M | -6.46% |
2015 | 285.60M | -1047.43% |
2014 | -30144053.92 | -128.91% |
The current Enterprise Value of Active Biotech AB (publ) (ACTI.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
52.29M
5-year avg
69.54M
10-year avg
147.87M
Active Biotech AB (publ)’s Enterprise Value is less than BioInvent International AB (publ) (2.25B), less than Orexo AB (publ) (837.85M), less than Alligator Bioscience AB (publ) (462.63M), less than Swedish Orphan Biovitrum AB (publ) (128.57B), greater than Anoto Group AB (publ) (76.70M),
Company | Enterprise Value | Market cap |
---|---|---|
2.25B | $2.96B | |
837.85M | $378.95M | |
462.63M | $501.82M | |
128.57B | $111.69B | |
76.70M | $53.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Active Biotech AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Active Biotech AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Active Biotech AB (publ)'s Enterprise Value?
What is the highest Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?
What is the 3-year average Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?
What is the 5-year average Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?
How does the current Enterprise Value for Active Biotech AB (publ) (ACTI.ST) compare to its historical average?